These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3234596)

  • 21. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.
    Kamen L; Henney HR; Runyan JD
    Curr Med Res Opin; 2008 Feb; 24(2):425-39. PubMed ID: 18167175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population.
    Smith HS; Barton AE
    Am J Hosp Palliat Care; 2000; 17(1):50-8. PubMed ID: 11094920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.
    Wagstaff AJ; Bryson HM
    Drugs; 1997 Mar; 53(3):435-52. PubMed ID: 9074844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of tizanidine in the treatment of spasticity.
    Neurology; 1994 Nov; 44(11 Suppl 9):S1-80. PubMed ID: 7970005
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tizanidine withdrawal symptoms in stress cardiomyopathy].
    Mörkl S; Bengesser SA; Schöggl H; Bayer D; Kapfhammer HP
    Fortschr Neurol Psychiatr; 2015 Mar; 83(3):170-3. PubMed ID: 25794323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tizanidine as treatment of spasticity in patients with hemiplegia caused by a CVA or brain injury].
    Weynants L; Van Laere M
    Acta Belg Med Phys; 1990; 13(1):19-22. PubMed ID: 2336897
    [No Abstract]   [Full Text] [Related]  

  • 28. [New therapies for spastic movement disorders].
    Benecke R; Patejdl R
    MMW Fortschr Med; 2009 Oct; 151 Suppl 3():118-22. PubMed ID: 20623938
    [No Abstract]   [Full Text] [Related]  

  • 29. Symptomatic bradycardia probably due to tizanidine hydrochloride in a chronic hemodialysis patient.
    Kitabata Y; Orita H; Kamimura M; Shiizaki K; Narukawa N; Abe T; Kobata H; Akizawa T
    Ther Apher Dial; 2005 Feb; 9(1):74-7. PubMed ID: 15828911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spasticity: a review.
    Young RR
    Neurology; 1994 Nov; 44(11 Suppl 9):S12-20. PubMed ID: 7970006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on tizanidine for muscle spasticity and emerging indications.
    Malanga G; Reiter RD; Garay E
    Expert Opin Pharmacother; 2008 Aug; 9(12):2209-15. PubMed ID: 18671474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tizanidine--initial pharmacokinetic studies in patients with spasticity.
    Heazlewood V; Symoniw P; Maruff P; Eadie MJ
    Eur J Clin Pharmacol; 1983; 25(1):65-7. PubMed ID: 6617726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of tizanidine action on spasticity.
    Milanov I; Georgiev D
    Acta Neurol Scand; 1994 Apr; 89(4):274-9. PubMed ID: 8042446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological analysis of the mode of action of muscle relaxants in spasticity.
    Delwaide PJ
    Ann Neurol; 1985 Jan; 17(1):90-5. PubMed ID: 3985591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of Microemulgel for Tizanidine Hydrochloride.
    Jagdale S; Brahmane S; Chabukswar A
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):158-179. PubMed ID: 30854978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tizanidine in the treatment of spasticity.
    Newman PM; Nogues M; Newman PK; Weightman D; Hudgson P
    Eur J Clin Pharmacol; 1982; 23(1):31-5. PubMed ID: 6751834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tizanidine in cranial dystonia.
    Lang AE; Riley DE
    Clin Neuropharmacol; 1992 Apr; 15(2):142-7. PubMed ID: 1591739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tizanidine administration on exteroceptive suppression of the temporalis muscle in patients with chronic tension-type headache.
    Nakashima K; Tumura R; Wang Y; Shimoda M; Sakuma K; Takahashi K
    Headache; 1994 Sep; 34(8):455-7. PubMed ID: 7960728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically Significant Bradycardia From Tizanidine.
    Masood U; Kahlon A; Mousa O
    Am J Ther; 2018; 25(3):e385-e386. PubMed ID: 28177941
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis.
    Nance PW; Sheremata WA; Lynch SG; Vollmer T; Hudson S; Francis GS; O'Connor P; Cohen JA; Schapiro RT; Whitham R; Mass MK; Lindsey JW; Shellenberger K
    Arch Neurol; 1997 Jun; 54(6):731-6. PubMed ID: 9193208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.